Glucose Monitoring Devices Market Set for Rapid Expansion to USD 67.74 Billion by 2033, Driven by Continuous Glucose Monitoring Adoption and Rising Global Diabetes Burden

The Glucose Monitoring Devices Market reached US$ 16.65 billion in 2024 and is expected to reach US$ 67.74 billion by 2033, growing at a strong CAGR of 17.0% during the forecast period 2025-2033. Market growth is primarily driven by the rising prevalence of diabetes worldwide, increasing adoption of continuous glucose monitoring (CGM) technologies, growing preference for real-time and minimally invasive monitoring solutions, and the shift toward home-based and digital diabetes management.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/glucose-monitoring-devices-market?jd

Global Key Industry Developments
The glucose monitoring devices landscape is rapidly evolving with advancements in sensor accuracy, wearable technologies, and data integration with digital health platforms.
✅ November 2025: Leading medical device companies are expected to introduce next-generation CGM systems with extended wear duration, improved accuracy, and reduced calibration requirements to enhance patient convenience.
✅ October 2025: Manufacturers are projected to expand smartphone-integrated glucose monitoring platforms, enabling seamless data sharing with healthcare providers and AI-driven glucose analytics.
✅ September 2025: Increased focus is anticipated on non-invasive and minimally invasive glucose monitoring technologies, aiming to improve patient compliance and long-term diabetes management outcomes.

Key Mergers and Acquisitions (2025):
✅ Technology Integration and Portfolio Expansion: In 2025, major medical device companies are actively pursuing acquisitions of digital health and sensor technology firms to strengthen continuous monitoring capabilities and enhance connected diabetes care ecosystems.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=glucose-monitoring-devices-market
(Purchase 2 or more Reports and get 50% Discount)

Market Segmentation Analysis
-By Device Type: Continuous Glucose Monitoring Devices Dominate
Continuous Glucose Monitoring Devices represent the leading segment, accounting for 58.14% of the overall market share. Their dominance is driven by real-time glucose tracking, reduced finger-prick dependence, improved glycemic control, and strong adoption among Type I and insulin-dependent Type II diabetes patients. Self-Monitoring Devices continue to be widely used, particularly in cost-sensitive markets and for routine glucose checks.

-By Indication: Diabetes Type II Leads Demand
Diabetes Type II accounts for the largest share of the market due to its high global prevalence and growing incidence linked to lifestyle changes and aging populations. Diabetes Type I drives strong adoption of CGM systems, while Gestational Diabetes represents a steadily growing segment due to rising maternal health awareness and screening programs.

-By End User: Home Setting Gains Strong Momentum
Hospitals, Clinics, and Diagnostic Centers remain key end users for glucose monitoring devices. However, the Home Setting segment is witnessing rapid growth due to the availability of user-friendly devices, remote monitoring capabilities, and increasing patient preference for self-management. Ambulatory Settings are also expanding with the rise of outpatient diabetes care.

Regional Insights
North America dominated the global Glucose Monitoring Devices Market, accounting for 42.3% of the market share in 2024. The region's leadership is supported by high diabetes prevalence, strong reimbursement frameworks, early adoption of advanced CGM technologies, and the presence of major medical device manufacturers. Asia-Pacific accounted for 21.5% of the market share in 2024 and represents a high-growth region, driven by a rapidly increasing diabetic population, improving healthcare infrastructure, rising awareness of diabetes management, and expanding access to advanced monitoring devices across countries such as China, India, and Japan. Europe continues to witness steady growth, supported by favorable regulatory frameworks, aging populations, and increasing adoption of digital health solutions.

Growth Drivers:
1. Rising Global Diabetes Prevalence: Increasing incidence of Type I and Type II diabetes is fueling sustained demand for glucose monitoring solutions.
2. Rapid Adoption of Continuous Glucose Monitoring Systems: CGMs offer real-time insights, better glycemic control, and improved patient outcomes.
3. Shift Toward Home-Based and Remote Monitoring: Growing preference for self-care and telehealth-enabled diabetes management is boosting device adoption.
4. Technological Advancements in Sensors and Wearables: Innovations are improving accuracy, comfort, and usability of glucose monitoring devices.
5. Integration with Digital Health Platforms: Data connectivity, analytics, and mobile applications are enhancing personalized diabetes care.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/glucose-monitoring-devices-market?jd

Key Players:
The major global players in the Glucose Monitoring Devices Market include Abbott Laboratories, Medtronic, F. Hoffmann-La Roche Ltd, LifeScan IP Holdings, LLC, Sanofi SA, B Braun Melsungen AG, Dexcom, Senseonics, Inc., Nova Biomedical Corporation, and Omnis Health LLC, among others.

Key Highlights (Top 5 Key Players):
1. Abbott Laboratories is a global leader in CGM technology, with strong adoption of its sensor-based glucose monitoring systems.
2. Dexcom specializes in advanced continuous glucose monitoring solutions with strong integration into digital health ecosystems.
3. Medtronic offers comprehensive diabetes management solutions, including CGM systems and insulin delivery integration.
4. F. Hoffmann-La Roche Ltd maintains a strong presence in self-monitoring blood glucose devices with a broad global footprint.
5. Senseonics, Inc. focuses on implantable CGM technologies designed for long-term glucose monitoring and improved patient convenience.

Unlock 360° Market Intelligence with DataM Intelligence Subscription Services:
https://www.datamintelligence.com/reports-subscription?jd
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape Analysis
✅ Company Profile Analysis
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updates
✅ Live Market & Pricing Trends
✅ Regulatory and Supply-Chain Analysis
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.